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Impact of Sleep Apnea 
 
 
 
Epidemiological studies have indicated that OSA affects 6–13% of the 
adult population. OSA is multifactorial disease, also considered as 
metabolic syndrome, which diagnosis in early stages is challenging 
thus often remain undiagnosed. Recently was  found connection 
between transthyretin (TTR) protein modifications present in human 
plasma samples and appearance of sleep apnea syndrome1,2 . Mass 
Spectrometric Immunoassay (MSIA) was successfully applied 
previously on identification of and quantification of TTR variants 
present in human serum3. We took advantage on this powerful method 
to investigate possible modifications of TTR proteoforms in patients 
with OSAS. 
Obstructive sleep apnea (OSA) is a common 
sleep-related breathing disorder which is 
characterized by recurrent occurrence of partial 
or complete closure of the upper airway during 
sleep, despite ongoing efforts to breathe. The 
majority of patients with OSA remain 
undiagnosed since most of them only come to 
the attention of a clinician when they complain of 
daytime sleepiness or when their bed partners 
report loud snoring or witnessed apnea episodes.  
 
Background 
Biological specimen: Cohort of 84 male patients, with clinically suspected 
diagnosis of obstructive sleep apnea (OSA) syndrome were undergo 
polysomnography  (PSG) – gold standard in diagnosis of OSA. Before PSG study, all 
subjects underwent a restricted diet during three days, including no drugs to 
induce sleep. The PSG was performed overnight at the sleep laboratory according 
to standard procedures. Blood from all examined individuals were collected before 
and after PSG, thus referred as evening and morning samples. Until analysis 
samples are stored at -800C. According to respiratory disturbance index (RDI) 
patients were classified as control (n = 20, diagnosed with primary snoring, RDI  < 
5/h) , mild (n = 30, RDI ≥ 5/h, but <15/h), moderate (n = 12, RDI ≥ 15/h, but <30/h) 
and severe OSA (n= 22, RDI ≥ 30/h). 
 
Sample preparation: MSIA with TTR specific immunoaffinity columns were 
used to perform individual analysis of plasma samples of all examined subjects. All 
measurements were performed in two replicates. Prepared samples are analyzed 
on Bruker´s, Ultraflex MALDI-TOF-TOF mass spectrometry instrument. 
 
Methods 
Illustration of steps involved 
in MSIA sample preparation  
Statistical data analysis: Statistical analysis was performed in R. Kruskal-Wallis (KW) test was used as a first 
approach to identify the parameters that should be further investigated. Parameters for which KW p-value <0.10 were 
subject to pairwise comparison among groups using Dunn’s test. Linear regression was used to to estimate reçationship 
between parameters and RDI. 
Results and Discussion 
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Fig. 1. Typical MS spectra of TTR proteoforms originating from 
human plasma samples 
A representative mass spectrum resulting from MSIA 
analysis of the plasma of the examined individuals is 
presented on Figure 1. Targeted protein is 
transthyretin (TTR). However, due to genetic 
mutations and post translational modifications TTR is 
appearing as multiple signal. The predominant form is 
cysteinylated TTRCys (MW=13,880.8 Da), followed by 
the native TTRn (MW=13,760.9 Da) and cysteinyl-
glycine TTRCysGly (MW=13,943.9 Da)form. Also it can 
be noted in the mass spectra are signals assigned to 
oxidation form of TTRox (MW=13,792.8), sulfonation 
TTRs (MW 13,842.3 Da) and Cysteine-Glycine 
transformation TTRCys10Gly(MW=13,717.6 Da). All of 
these TTR variants occur as a result of the 
modifications of a single highly reactive cystein 
residue (Cys10).  Its of the great importance to 
analyze this proteoforms due to the crucial role of the 
free Cys10 residue and possible involvement of 
pathophysiological factors that affect Cys 10 reactivity. 
Data mining: 
Intensities of the MS signals the TTR proteoforms were measured. Our goal was to investigate how these data modify 
related to OSA pathology.  To achieve that we followed changes in proteoform expression before and after sleep 
(evening- morning variations). Also we observed changes of TTR variants longitudinally – between groups. 
• Results  of KW test of samples taken before PSG (evening) revealed  that  all proteoforms except  TTRox are 
significantly downregulated  in individuals with OSA when compared to snorer group (Fig. 2). However, Dunn test 
revealed that TTRCys10Gly and TTRCysGly distribute differently according to OSA severity with statistical significance 
(α=0.1). 
• Levels of TTR variants in the morning samples are not differ between groups 
• Correlation model exhibit statistically significant linear dependence of TTRCys10Gly, TTRn and TTRCysGly on RDI for 
significance level of 10% (Fig.3). In other words for unit increment of RDI, there is stat. significant decrease in value of 
protein signal intensity.   
• Evening-morning differences are also stat. significant for the TTRCys, TTRn, TTRs and TTRCysGly. However, post-hoc 
Dunn test revealed that only evening-morning difference of TTRCysGly are statistically significant depending on OSA 
pathology level. 
• Following differences on evening-morning TTR´s expression it noticed strong positive dependence on RDI for 
following TTR variants: TRCys, TTRn, TTRCysGly  and TTRs. This findings suggest that in spite of breathing disturbance 
some reparation mechanisms are triggered toward maintenance of TTR-stasis. 
• Most of the patients are obese, thus abdominal perimeter is one of the factors which is followed in routine physical 
examination of OSA suspected patients. We wish to test hypothesis that some of the TTR variants can be brought in 
correlation with abdominal parameter, offering the possibility to triage OSA suspected individuals before they are 
sent to PSG. On Fig.5 is presented correlation of the abdominal parameter on RDI. Cysteinil-Glycine variant of TTR in 
the samples taken before PSG, exhibited highest correlation with RDI and abdominal parameter hence suggested that 
can be consider as potential new biomarker for OSA. 
 
 
 
Conclusion 
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Fig. 5. Linear dependence of the abdominal perimeter 
on RDI 
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Obstructive sleep apnea (OSA) is an underdiagnosed common public health concern causing 
deleterious effects on metabolic and cardiovascular health. Gold standard for diagnosis is 
polysomnography and it can be only done in hospitals and specialized sleep clinics. Recent studies 
found connection between TTR protein modifications present in human plasma samples and 
appearance of sleep apnea syndrome. In our work we investigated expression of TTR proteoforms in 
individuals with different severity of OSA. This findings revelad that before sleep 5 of totaly 6 
identified TTR variants are significantly decreased comparing to control snorers, while cysteinyl-
glycine modification (TTRCysGly) has strong  significance in differentating OSA severity. Analysis of 
morning samples revealed that reparation mechanisms are triggered during sleep resulting in 
balanced levels of TTR proteoforms between all groups. Both, evening levels of individual TTR 
variants and evening-morning difference have significant dependence on RDI. However, change in 
TTRCysGly expression is highlighted because it significantly correlates with RDI values,  OSA severity 
and abdominal perimeter. This findings make TTRCysGly new putative biomarker for screening of 
OSA patients and potentially great addition to further OSA diagnosis. To validate obtained results 
MSIA-TTR analysis on large cohorts are need. Pathophysiological mechanisms behind these changes 
on TTR is still to be elucidated. 
